Hematopathology Fellowship

血液病理学研究金非常成功地吸引了优秀的申请者，并为他们提供了血液病理学方面的培训，强调杰出的临床诊断，以及包括分子诊断和流式细胞术在内的专门诊断工具。该奖学金自2000年以来一直获得ACGME认证，毕业学员在美国病理委员会颁发的认证考试中首次通过率接近100%。毕业生继续在学术医学领域建立独立的职业生涯，包括近年来在莫菲特癌症中心、洛约拉大学、卫理公会医院(威尔·康奈尔医学院)、加州大学戴维斯分校、梅奥诊所、纪念斯隆·凯特琳癌症中心和克利夫兰诊所的任命。两名新近毕业的学生成功争取到了国立卫生研究院的独立资助。鼓励研究员参与临床研究，并已成功完成各种主题的研究，如下所述。宋永元，L.Xi，M.Raffeld，N.L.Harris，W.H.Wilson，S.Pittaluga和E.S.Jaffe(2012)。皮肤CD30阳性T细胞淋巴瘤模仿经典霍奇金淋巴瘤累及结节。Am J Surg Pathol 36(5)：716-25.Huppmann，A.，M.Roullet，M.Raffeld和E.Jaffe(印刷中)血管免疫母细胞性T细胞淋巴瘤部分被EBV阴性的克隆性浆细胞增殖所掩盖。《临床肿瘤学杂志》，Jegian，A.G.，F.C.Eberle，S.D.Pack，M.Mirvis，M.Raffeld，S.Pittaluga和E.S.Jaffe(2011)。原位滤泡性淋巴瘤：临床意义及与滤泡性淋巴瘤部分受累的比较。血液118(11)：2976-84.Menon，M.P.，A.Jegalion，M.Raffeld，S.Pittaluga，L.xi和E.S.Jaffe(2012)。原发性中枢T细胞淋巴瘤：临床、形态、免疫表型和分子分析现代病理学25：355A-355A。Song，J.Y.，T.Strom，M.Raffeld，S.Pittaluga和E.S.Jaffe(2011)。CD30、CD15和CD20异常表达的外周T细胞淋巴瘤。J Clin Oncol.Summers，T.A.，F.C.Eberle，S.Pittaluga，W.H.Wilson，K.Dunliy，M.Raffeld，S.M.Hewitt and E.S.Jaffe(2011)。“灰色地带淋巴瘤：变得更黑更白。”《现代病理》24，增刊1。：324A。萨默斯，T.A.和E.S.Jaffe(2011)。“毛细胞白血病的诊断标准和鉴别诊断。”Leuk Lymphom.Venkataraman，G.，K.A.Rizzo，J.J.Chavez，B.Streubel，M.Raffeld，E.S.Jaffe和S.Pittaluga(2011)。“边缘地带淋巴瘤累及脑膜：可能与IgG4相关疾病有关。”《现代病理》24(3)：355-66.Venkataraman，G.，A.Traverse-Glehen，J.Y.Song，F.C.Eberle，J.C.Hanson，S.Dirnhofer，A.Tzankov，G.Heinze，M.A.Raffeld，S.Pittaluga和E.S.Jaffe(2011)经典霍奇金淋巴瘤中T细胞抗原的异常表达与无事件生存期(EFS)和总生存期(OS)的降低有关。“实验室调查91：326A-327A。

The Hematopathology Fellowship has been highly successful in attracting outstanding applicants and in providing them with training in hematopathology, emphasizing outstanding clinical diagnosis, and specialized diagnostic tools including molecular diagnostics and flow cytometry. The fellowship has been ACGME accredited since 2000, and graduating fellows have had a nearly a 100% first time pass rate on the accrediting examination given by the American Board of Pathology. Graduating fellows have gone on to establish independent careers in academic medicine, including appointments in recent years at the Moffit Cancer Center, Loyola University, The Methodist Hospital (Weill Cornell Medical School), The University of California -Davis, The Mayo Clinic, Memorial Sloan Kettering Cancer Center, and the Cleveland Clinic. Two of recent graduates have successfully competed for independent NIH funding. Fellows are encouraged to participate in clinical research, and have successfully completed studies on a variety of topics, as briefly mentioned below. Eberle, F. C., J. Y. Song, L. Xi, M. Raffeld, N. L. Harris, W. H. Wilson, S. Pittaluga and E. S. Jaffe (2012). "Nodal Involvement by Cutaneous CD30-positive T-cell Lymphoma Mimicking Classical Hodgkin Lymphoma." Am J Surg Pathol 36(5): 716-25.Huppmann, A., M. Roullet, M. Raffeld and E. Jaffe (in press ). "Angioimmunoblastic T-cell lymphoma partially obscured by an EBV-negative clonal plasma cell proliferation." Journal of Clinical Oncology.Jegalian, A. G., F. C. Eberle, S. D. Pack, M. Mirvis, M. Raffeld, S. Pittaluga and E. S. Jaffe (2011). "Follicular lymphoma in situ: clinical implications and comparisons with partial involvement by follicular lymphoma." Blood 118(11): 2976-84.Menon, M. P., A. Jegalion, M. Raffeld, S. Pittaluga, L. Xi and E. S. Jaffe (2012). "Primary CNS T-Cell Lymphomas: Clinical, Morphologic, Immunophenotypic and Molecular Analysis." Modern Pathology 25: 355A-355A.Song, J. Y., T. Strom, M. Raffeld, S. Pittaluga and E. S. Jaffe (2011). "Peripheral T-Cell Lymphoma With Aberrant Expression of CD30, CD15, and CD20." J Clin Oncol.Summers, T. A., F. C. Eberle, S. Pittaluga, W. H. Wilson, K. Dunleavy, M. Raffeld, S. M. Hewitt and E. S. Jaffe (2011). "Gray zone lymphomas: becoming more black and white." Mod Pathol 24, Suppl 1.: 324A.Summers, T. A. and E. S. Jaffe (2011). "Hairy cell leukemia diagnostic criteria and differential diagnosis." Leuk Lymphoma.Venkataraman, G., K. A. Rizzo, J. J. Chavez, B. Streubel, M. Raffeld, E. S. Jaffe and S. Pittaluga (2011). "Marginal zone lymphomas involving meningeal dura: possible link to IgG4-related diseases." Mod Pathol 24(3): 355-66.Venkataraman, G., A. Traverse-Glehen, J. Y. Song, F. C. Eberle, J. C. Hanson, S. Dirnhofer, A. Tzankov, G. Heinze, M. A. Raffeld, S. Pittaluga and E. S. Jaffe (2011). "Aberrant T-Cell Antigen Expression in Classical Hodgkin Lymphoma Is Associated with Decreased Event-Free Survival (EFS) and Overall Survival (OS)." Laboratory Investigation 91: 326A-327A.